{"task_id": "d6ab61e9be606eff", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 312/464)", "text": "NICAL FEATURES (CONT\u2019D)\n302\nAcute Stroke Syndromes\n\n--- Page 324 ---\nTREATMENT ISSUES (CONT\u2019D)\n\u0002\nEXCLUSION\nhistorical (time of symptom onset\nunknown, prior history of ICH, stroke/head trauma\n<3 months, MI <3 months, major surgery/trauma\n<14 days, GI/GU bleed <21 days, arterial puncture\nin non compressible site <7 days, combination of\nprevious stroke and DM, oral anticoagulant treat\nment, coagulopathy), clinical (rapidly improving\nstroke symptoms, minor/isolated symptoms, seizure\nat onset of stroke with residual impairment second\nary to postictal phenomenon, suspicion of SAH,\nacute MI/post MI pericarditis, persistent hyperten\nsion\u0003185/110), labs (platelet <100\u0005109/L, glucose\n<2.8 mM [50 mg/dL], or >22.2 mM [400 mg/dL], \"\nPTT), CT head (hemorrhage, major early infarct\nsigns), severe stroke as assessed clinically (NIH\nTREATMENT ISSUES (CONT\u2019D)\nscore >25) or radiographically (stroke involving\n>1/3 of cerebral hemisphere)\n\u0002\nOUTCOME\namong patients receiving thrombolysis\nwithin 3 h of onset, favorable outcomes in 31 50%\nof treated patients compared to 20 38% of non\ntreated patients at 3 months and 1 year. Patients\nbenefit more if treated early (<90 min) but benefit\nextends out to 6 h. Major risk is symptomatic brain\nhemorrhage (3 5%). However, mortality rate is simi\nlar between the two groups at 3 months and 1 year.\nThrombolysis administered between 3 and 4.5 h\nafter symptom onset associated with favorable out\ncome in 52.4% compared to 45.2% in non treated\npatients, with an increased risk of intracranial\nhemorrhage, but no effect on mortality\nRELATIVE RISK REDUCTION FOR ISCHEMIC STROKE/TIA\nCondition\nPrimary prophylaxis\nSecondary prophylaxis\nHypertension\nAnti HTN 20%\nAnti HTN 28%\nHyperlipidemia\nStatins\nStatins\nAtrial fibrillation\nASA 20 30%\nCoumadin 60%\nASA 20 30%\nCoumadin 60%\nPost MI\nASA 31%\nASA\nPost stroke\nNo needed if no previous stroke\nASA 30%\nClopidogrel 43%\nASA/persantine 43%\nThe percentages in this table represent relative risk reduction\nCRITERIA FOR CAROTID ENDARTERECTOMY\nCarotid stenosis\nSymptomatic\nAsymptomatic\n\u000370%\nYes (NNT 6.3)\nYes for men with stenosis \u000360% only (NNT 33)\n50 69%\nYes for men only (NNT 22)\n<50%\nNo\nNo\nNNT=number needed to treat. Medical management (ASA) for those not eligible for carotid endarterectomy\nSPECIFIC ENTITIES\nDISTINGUISHING FEATURES BETWEEN UPPER MOTOR NEURON AND LOWER MOTOR NEURON\nLESIONS\nUpper motor neuron\nLower motor neuron\nInspect\nAtrophy after long term\nAtrophy and fasciculations\nTone\nSpasticity\nFlaccidity\nStrength\nUpper limbs flexors >extensors pronation\n>supination\nLower limbs extensors >flexors\nNerve root/peripheral nerve\ndistribution\nReflex\nIncreased with clonus\nBabinski upgoing\nDecreased\nBabinski downgoing\nPronator drift\nPresent\nAbsent\nAPHASIA (LANGUAGE IMPAIRMENT)\n\u0002\nTESTING PHRASES\n\u0002\nCOMPREHENSION WITHOUT REPLY\n\u2018\u2018Touch your\nchin, then your nose, then your ear\u2019\u2019\nSPECIFIC ENTITIES (CONT\u2019D)\n\u0002\nCOMPREHENSION WITH ANSWERS\n\u2018\u2018Do you put\nyour shoes on before your socks?\u2019\u2019\n\u0002\nFLUENCY\n\u2018\u2018Describe your daily activities.\u2019\u2019\n\u0002\nNAMING\n\u2018\u2018Name this object.\u2019\u2019 (e.g. pen)\n\u0002\nREPETITION\n\u2018\u2018No ifs, ands, or buts.\u2019\u2019\nSPECIFIC ENTITIES (CONT\u2019D)\nAcute Stroke Syndromes\n303", "text_length": 3137, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 312/464)", "type": "chunk", "chunk_index": 311, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.676011", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.676811", "status": "complete", "chunks_added": 2}